SBMA – Diane Merry, Ph.D.

SBMA - Diane Merry, Ph.D.
Diane Merry previously has received funding from MDA — both as a postdoctoral fellow, and again when she started her lab. “It means a tremendous amount to me to be funded once again by this organization that is so committed to finding a cure for neuromuscular diseases,” she said.

Diane Merry, associate professor at Thomas Jefferson University in Philadelphia, was awarded an MDA research grant totaling $300,000 over three years to identify therapeutic opportunities to promote normal androgen receptor function while preventing the toxic effects of polyglutamine expansion in spinal-bulbar muscular atrophy (SBMA). Working with GlaxoSmithKline, Merry will test small molecule compounds that activate an enzyme called SIRT1 in cell and mouse models of SBMA to determine their therapeutic potential.

Funding for this MDA research grant began Aug. 1, 2015.